China Medical (600056.SH): The hydrochloride betahistine tablets and other drugs are expected to be selected for the national centralized procurement of pharmaceuticals.

Zhuhong Finance APP reports that China National Pharmaceutical Group Corporation (600056.SH) announced that on July 31, 2026, its subsidiary participated in the bidding for the 12th batch of national drug centralized procurement. According to the provisional results announced on-site by the National Drug Joint Procurement Office, the companys products, including Betahistine Hydrochloride Tablets, Vornorex Tablets, Vitamin B6 Injection, Sacubitril Valsartan Sodium Tablets, Injection of Isavuconazole Sulfate, Edoxaban Tosylate Tablets, Carglumic Acid Injection, and Valaciclovir Hydrochloride Tablets, are likely to be selected for this centralized procurement.